1 / 6

Urinary Incontinence Market Research Growth by Manufacturers, Regions, Type and

Urinary Incontinence Market <br>

27354
Download Presentation

Urinary Incontinence Market Research Growth by Manufacturers, Regions, Type and

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Urinary Incontinence Market To Reach USD 3.93 Billion By 2026

  2. Market Summary According to the current analysis of Reports and Data, the global Urinary Incontinence market was valued at USD 2.18 billion in 2018 and is expected to reach USD 3.93 billion by the year 2026, at a CAGR of 7.6%. Urinary incontinence is the leakage of urine, which is not controllable and is caused due to loss of control on the bladder. The various factors which are responsible for urine leakage include multiple conditions such as pregnancy, menopause, pelvic surgery, spinal surgery, diabetes, childbirth, and post radical prostatectomy surgery. The crucial factors responsible for propelling the market include the rising prevalence of the physical and medical conditions leading to urinary incontinence, increase in the geriatric population in the forecast period. For instance, according to the International Diabetes Federation estimates, half a billion people are found to be living with diabetes worldwide, and the number is projected to increase by 25% in 2030 and 51% in 2045. This rise in diabetic patients who undergo problems with urination is anticipated to fuel the market in the near future.

  3. Our Approach Our Approach Market Summary Scope of the Report- The report discusses recent trends and developments seen in the market to analyze the growth opportunities and challenges existing in the industry to help readers better understand the business landscape and make decisions accordingly. It includes a description of all the factors that are beneficial for the future growth of the sector to highlight investment prospects for readers. The research study also offers actionable insights to help readers capitalize on opportunities and challenges existing in the global industry and undertake lucrative strategies to get ahead in the competition. Key participants include Covidien plc (Medtronic), Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc., Cook Medical, Prosurg, Inc., and Cogentix Medical Inc. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2741

  4. Our Approach Our Approach Market Summary For the purpose of this report, Reports and Data have segmented the market on the basis of process type, grade, application, end-use, and region: Types Outlook (Revenue in Million USD; 2016–2026) Stress Urge Mixed Overflow Functional Total Incontinence Others End-Use Outlook (Revenue in Million USD; 2016–2026) Hospitals Clinics Ambulatory Surgical Centers Home Use Others

  5. Our Approach Our Approach Market Summary Further key findings from the report suggest According to the classification given by the Food and Drug Administration, the mesh, surgical, synthetic, urogynecology, was declared implantable conferring to the Life-Saving and Life-Sustaining Devices for purposes of Section 614 of FDASIA amending Section 519(f) of the FDC Act. The approval of such products is expected o fuel the growth of the market in the coming years. In Jan 2020, Medtronic received CE mark for the rechargeable sacral neuromodulation technology for its InterStim Micro neurostimulator and InterStim SureScan MRI leads, clearing the technologies for sale in Europe. The global market leaders are developing technologies to combat the competition for the growing need for minimally invasive urinary incontinence devices which are anticipated to boost the market. For instance, recently Axonics won FDA approval for the first rechargeable sacral neuromodulation device. The increasing appreciations for the technological advancements would allow upsurge in the innovation in the coming years. For instance, in 2019 UroMems, a developer of the eAUS electronic artificial urinary sphincter received the 2019 Prix Galien USA Med’Start-Up Award for best collaboration in the Medtech or digital sector for its collaboration with the Mayo Clinic to design a clinical study for a novel medical device to treat patients with stress urinary incontinence (SUI) Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/2741

  6. Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related